Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05693545

GOALIE: Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent RHD Trial

Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent Rheumatic Heart Disease: A Non-inferiority Randomized Trial

Status
Active Not Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
1,004 (estimated)
Sponsor
Children's Hospital Medical Center, Cincinnati · Academic / Other
Sex
All
Age
5 Years – 17 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to determine if twice daily oral penicillin prophylaxis is non-inferior to monthly IM penicillin prophylaxis in preventing latent Rheumatic Heart Disease Progression in children between the ages of 5-17 years. The main objective is to compare the proportion of children aged 5-17 years with latent RHD receiving oral penicillin prophylaxis who progress to worse valvular disease at 2-years compared to children who receive IM penicillin prophylaxis.

Detailed description

GOALIS is a randomized controlled trial developed to provide high quality contemporary evidence on the efficacy of oral penicillin as RHD prophylaxis. Aim 1: To compare the proportion of children aged 5-17 years with latent RHD receiving oral penicillin prophylaxis who progress to worse valvular disease at 2-years compared to children who receive IM penicillin prophylaxis. Aim 2: To evaluate the economic equivalence and cost-effectiveness of oral penicillin compared to IM penicillin, after echocardiographic screening for latent RHD detection. Aim 3: Compare patient-reported outcomes (treatment acceptance, treatment satisfaction, and health-related quality of life) between children receiving oral and IM penicillin prophylaxis.

Conditions

Interventions

TypeNameDescription
DRUGphenoxymethyl penicillinProphylaxis
DRUGintramuscular benzathine penicillin G (BPG) prophylaxisProphylaxis

Timeline

Start date
2023-09-01
Primary completion
2027-03-31
Completion
2027-09-30
First posted
2023-01-23
Last updated
2026-03-17

Locations

1 site across 1 country: Uganda

Source: ClinicalTrials.gov record NCT05693545. Inclusion in this directory is not an endorsement.